Should anti-TNF-alpha therapy be offered to patients with infertility and recurrent spontaneous abortion?
Clark
David A
DA
McMaster University, 1200 Main St. West. Rm 3V39, Hamilton, ON, Canada L8N3Z5. clarkd@mcmaster.ca
D000026:Abortion, Habitual / Q000188:drug therapy*; D000068879:Adalimumab; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy*; D051379:Mice; D011247:Pregnancy; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab